PSDV, BLKB, CO, BAB, DISCA, MDSO Are Seasonally Ripe To Go Up In the Next Five Weeks
February 15, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of pSivida Corp. (NASDAQ:PSDV), Blackbaud Inc. (NASDAQ:BLKB), China Cord Blood Corporation (NYSE:CO), PowerShares Build America Bond Portfolio (NYSE:BAB), Discovery Communications Inc. (NASDAQ:DISCA), Medidata Solutions Inc. (NASDAQ:MDSO) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date PSDV pSivida Corp. 19.55% 87.50% (7 of 8) Wednesday, March 22nd 2017 BLKB Blackbaud Inc. 6.13% 100.00% (12 of 12) Thursday, March 30th 2017 CO China Cord Blood Corporation 4.84% 87.50% (7 of 8) Thursday, March 30th 2017 BAB PowerShares Build America Bond Portfolio 1.18% 85.71% (6 of 7) Tuesday, February 28th 2017 DISCA Discovery Communications Inc. 7.46% 87.50% (7 of 8) Monday, March 6th 2017 MDSO Medidata Solutions Inc. 7.27% 85.71% (6 of 7) Wednesday, March 1st 2017pSivida Corp. (NASDAQ:PSDV) - pSivida Corp. develops sustained-release drug-delivery products for the treatment of chronic eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior segment uveitis. The company is also developing Medidur, an injectable, sustained-release micro-insert, which is in Phase III clinical trials for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Its pre-clinical development program focuses on developing products using its core platform technologies, Durasert and Tethadur, to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. The company has strategic collaborations with Alimera Sciences, Inc.; Pfizer, Inc.; Bausch & Lomb Incorporated; and Enigma Therapeutics Limited. pSivida Corp. was founded in 1987 and is headquartered in Watertown, Massachusetts..
Blackbaud Inc. (NASDAQ:BLKB) - Blackbaud, Inc. provides software solutions and related services for nonprofit, education institutions, healthcare organizations, foundations, charitable giving entities, and corporations worldwide. It operates in three segments: General Markets Business Unit, Enterprise Customer Business Unit, and International Business Unit. The company offers Raiser's Edge NXT designed to manage constituent relationship management (CRM) and fundraising activity; Blackbaud CRM, a fundraising and relationship management solution; Luminate CRM for campaign management, constituent relations, business intelligence, and analytics; eTapestry, a cloud-based donor management and fundraising solution; and Everyday Hero, a cloud-based crowdfundraising solution. It also provides solutions for donor acquisition, prospect research, data enrichment, and performance management; and customer support and maintenance, payment processing, professional, and training services. In addition, the company offers Luminate Online that builds online fundraising campaigns; Blackbaud Online Express, a cloud-based fundraising and marketing tool; Blackbaud NetCommunity, an online marketing and communications tool; Financial Edge NXT, an accounting solution; GIFTS Online, a cloud-based solution; FIMS, an on-premise foundation management system; and Blackbaud Outcomes that empowers funders and nonprofits. Further, it provides onMessage, a content management system; onRecord, a new student information system; onCampus, a learning management system; onBoard, an enrollment management system; Smart Tuition, a solution that helps administrative staff; Smart Aid, a proprietary hobbies, interest, and lifestyles profile; Altru, a cloud solution that helps arts and cultural organizations; and AngelPoints, an integrated corporate social responsibility solution. Blackbaud, Inc. was founded in 1981 and is headquartered in Charleston, South Carolina..
China Cord Blood Corporation (NYSE:CO) - China Cord Blood Corporation, together with its subsidiaries, primarily provides umbilical cord blood storage and ancillary services in the People s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as offers matching services. As of March 31, 2016, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company has a strategic collaboration with Cord Blood Registry to share data on cord blood collection, processing, and storage. China Cord Blood Corporation is based in Central, Hong Kong..
PowerShares Build America Bond Portfolio (NYSE:BAB) - British Airways PLC.
Discovery Communications Inc. (NASDAQ:DISCA) - Discovery Communications, Inc. operates as a media company worldwide. It operates through U.S. Networks; International Networks; and Education and Other segments. The company owns and operates various television networks under the Discovery Channel, TLC, Animal Planet, Investigation Discovery, Science, Velocity, Discovery Family, American Heroes, Destination America, Discovery Life, Oprah Winfrey Network, Eurosport, DMAX, and Discovery Kids brands. Its content spans genres, including survival, exploration, sports, lifestyle, general entertainment, heroes, adventure, crime and investigation, health, and kids. The company also develops and sells curriculum-based education products and services comprising online suite of curriculum-based VOD tools, professional development services, and digital textbooks, as well as student assessments; and publishes hard copy curriculum-based content for K-12 schools. In addition, it operates production studios that develop content for television service providers, as well as Websites. The company provides content through various distribution platforms, including pay-TV, free-to-air and broadcast television, digital distribution arrangements, and content licensing agreements, as well as various platforms, such as brand-aligned Websites, Web-native networks, on-line streaming, mobile devices, video on demand (VOD), and broadband channels. As of December 31, 2015, it operated approximately 380 distribution feeds in 40 languages internationally. The company is headquartered in Silver Spring, Maryland..
Medidata Solutions Inc. (NASDAQ:MDSO) - Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. The company offers applications and data analytics for clinical development. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. The company s platform includes Planning Cloud that provides capabilities for study design and planning; and Medidata Rave, an electronic data capture and management system solution. Its platform solutions also include Patient Cloud for direct capture of the voice of the patient in clinical trials; Medidata's mobile health that offer various ways for customers to utilize the measurements in the scientific, regulatory, and technology environment of clinical trials; Medidata Patient Cloud ePRO, an application for use on various app-ready iOS or Android device; and Study Management Cloud that enable clinical teams to manage, monitor, control, integrate, and report operational and clinical data from patients and sites. Further, the company s platform solutions include a set of risk-based monitoring tools and services that enable customers to assess data quality with risk-based strategies; Payments Cloud solution that automates the task of tracking and calculating payments to individual sites across clinical trials; and Data and Analytics Cloud to surface a range of embedded operational data across the clinical process. Additionally, it offers professional services. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, CROs, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net